Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis

医学 肾脏替代疗法 基数超额 内科学 代谢性碱中毒 急性肾损伤 负离子间隙 钙代谢 钙 胃肠病学 重症监护医学 代谢性酸中毒
作者
Wei Zhang,Ming Bai,Yan Yu,Lu Li,Lijuan Zhao,Shiren Sun,Xiangmei Chen
出处
期刊:Critical Care [BioMed Central]
卷期号:23 (1) 被引量:88
标识
DOI:10.1186/s13054-019-2317-9
摘要

Regional citrate anticoagulation (RCA) is a widely used strategy for continuous renal replacement therapy (CRRT). Most of the current guidelines recommend liver failure as one of the contraindications for citrate anticoagulation. However, some studies suggested that the use of citrate for CRRT in liver failure patients did not increase the risk of citrate-related complications. The purpose of this systematic review is to summarize the current evidences on the safety and efficacy of RCA for CRRT in liver failure patients. We performed a comprehensive search on PubMed, Embase, and the Cochrane Library databases from the inception to March 1, 2018. Studies enrolled adult (age > 18 years) patients with various levels of liver dysfunction underwent RCA-CRRT were included in this systematic review. After the study screening, 10 observational studies with 1241 liver dysfunction patients were included in this systematic review. The pooled rate of citrate accumulation and bleeding was 12% [3%, 22%] and 5% [2%, 8%], respectively. Compared with the baseline data, the serum pH, bicarbonate, and base excess (BE), the rate of metabolic alkalosis, the serum ionized calcium (ionCa) and total calcium (totCa) level, and the ratio of total calcium/ionized calcium (totCa/ionCa) significantly increased at the end of observation. However, no significant increase was observed in serum citrate (MD − 65.82 [− 194.19, 62.55]), lactate (MD 0.49 [− 0.27, 1.26]) and total bilirubin concentration (MD 0.79 [− 0.70, 2.29]) at the end of CRRT. Compared with non-liver failure patients, the live failure patients showed no significant difference in the pH (MD − 0.04 [− 0.13, 0.05]), serum lactate level (MD 0.69 [− 0.26, 1.64]), and totCa/ionCa ratio (MD 0.03 [− 0.12, 0.18]) during CRRT. The median of mean filter lifespan was 55.9 h, with a range from 22.7 to 72 h. Regional citrate anticoagulation seems to be a safe anticoagulation method in liver failure patients underwent CRRT and could yield a favorable filter lifespan. Closely monitoring the acid base status and electrolyte balance may be more necessary during RCA-CRRT in patients with liver failure.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
勤恳的板凳完成签到 ,获得积分10
刚刚
科研通AI6.2的应助被lhx采纳,获得10
1秒前
chen完成签到,获得积分10
1秒前
hml123发布了新的文献求助10
1秒前
cdercder的应助被栗子砸采纳,获得10
1秒前
2秒前
bobojiayou完成签到,获得积分10
2秒前
3秒前
知予完成签到 ,获得积分10
4秒前
笑点低的衬衫完成签到,获得积分10
5秒前
5秒前
6秒前
fairytaler的应助被arpege采纳,获得10
7秒前
孙子钊完成签到,获得积分10
8秒前
yuan完成签到 ,获得积分10
8秒前
安静葵阴发布了新的文献求助10
8秒前
yjswjf完成签到,获得积分20
9秒前
Empty发布了新的文献求助10
9秒前
10秒前
爆米花的应助被黑糖话梅采纳,获得10
10秒前
AI发布了新的文献求助10
10秒前
深情安青的应助被张兵采纳,获得10
11秒前
11秒前
李爱国的应助被yebo采纳,获得10
11秒前
11秒前
脑花完成签到,获得积分10
12秒前
万能图书馆的应助被Leon采纳,获得10
13秒前
pepsi191完成签到,获得积分10
13秒前
13秒前
14秒前
Hua发布了新的文献求助10
14秒前
眼睛大的之卉完成签到,获得积分10
14秒前
14秒前
15秒前
lan__完成签到,获得积分10
15秒前
情怀的应助被qqq采纳,获得10
15秒前
斯内克完成签到,获得积分10
15秒前
sui发布了新的文献求助10
16秒前
什么时候毕业完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239